AVNS Avanos Medical Inc

  1. Stocks
  2. Healthcare
  3. NYSE: AVNS

Price (delayed)

$20.89

Market cap

$969.83M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.18

Enterprise value

$1.17B

Avanos Medical, Inc. is a medical technology company focused on delivering clinical medical device solutions. The company consists of two franchises – Pain Management and Chronic Care – that address ...

Highlights
The revenue is up by 2.2% year-on-year
The EPS has plunged by 55% from the previous quarter
The net income has plunged by 54% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://avanos.com/
Peers: STE SYK

Key stats

What are the main financial stats of AVNS
Market
Shares outstanding
46.43M
Market cap
$969.83M
Enterprise value
$1.17B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.8
Price to sales (P/S)
1.31
EV/EBIT
N/A
EV/EBITDA
59.06
EV/Sales
1.56
Earnings
Revenue
$749.9M
EBIT
-$28.2M
EBITDA
$19.8M
Free cash flow
$36.6M
Per share
EPS
-$1.18
Free cash flow per share
$0.78
Book value per share
$26.07
Revenue per share
$16
TBVPS
$14.75
Balance sheet
Total assets
$1.72B
Total liabilities
$502.8M
Debt
$306.7M
Equity
$1.22B
Working capital
$353.9M
Liquidity
Debt to equity
0.25
Current ratio
3.07
Quick ratio
1.48
Net debt/EBITDA
10.08
Margins
EBITDA margin
2.6%
Gross margin
55.3%
Net margin
-7.4%
Operating margin
5.3%
Efficiency
Return on assets
-3.2%
Return on equity
-4.4%
Return on invested capital
-4%
Return on capital employed
-1.8%
Return on sales
-3.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AVNS stock price

How has the Avanos Medical stock price performed over time
Intraday
-1.92%
1 week
-1.28%
1 month
-3.82%
1 year
-20.18%
YTD
-22.8%
QTD
3.31%

Financial performance

How have Avanos Medical's revenue and profit performed over time
Revenue
$749.9M
Gross profit
$414.7M
Operating income
$39.4M
Net income
-$55.4M
Gross margin
55.3%
Net margin
-7.4%
Avanos Medical's net margin has plunged by 54% from the previous quarter
The net income has plunged by 54% from the previous quarter
Avanos Medical's operating margin has decreased by 23% YoY and by 9% from the previous quarter
The operating income is down by 22% YoY and by 9% QoQ

Growth

What is Avanos Medical's growth rate over time

Valuation

What is Avanos Medical stock price valuation
AVNS P/E details
P/E
N/A
P/B
0.8
P/S
1.31
EV/EBIT
N/A
EV/EBITDA
59.06
EV/Sales
1.56
The EPS has plunged by 55% from the previous quarter
AVNS's price to book (P/B) is 37% less than its 5-year quarterly average of 1.3 and 9% less than its last 4 quarters average of 0.9
The company's equity fell by 3.3% YoY
The P/S is 40% lower than the 5-year quarterly average of 2.2 and 17% lower than the last 4 quarters average of 1.6
The revenue is up by 2.2% year-on-year

Efficiency

How efficient is Avanos Medical business performance
The ROS has plunged by 139% YoY and by 65% from the previous quarter
AVNS's ROIC has plunged by 138% YoY and by 60% from the previous quarter
The ROE has plunged by 57% from the previous quarter
The return on assets has dropped by 52% since the previous quarter

Dividends

What is AVNS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AVNS.

Financial health

How did Avanos Medical financials performed over time
Avanos Medical's total liabilities has increased by 16% from the previous quarter
The quick ratio has declined by 9% year-on-year
Avanos Medical's debt is 75% less than its equity
Avanos Medical's debt has increased by 21% from the previous quarter
The debt to equity has grown by 19% from the previous quarter and by 4.2% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.